Do projections of future savings to society justify the seemingly exorbitant pricing of potentially life-saving drugs? Victor Roy takes apart the pharmaceutical industry's often specious rationale for high prices: "Underneath a veneer of long-term thinking hides a more pernicious pathology of short-termism. [...] The most important reason for treating a patient—their chance at health—is lost amid all the arithmetic. The consequences are significant."
Victor Roy is a MD candidate at Northwestern University and a PhD candidate in sociology and political economy at University of Cambridge. He is currently writing a history of the technological innovation, valuation, and ethics behind new curative therapies for patients with Hepatitis C.